Novel treatment of hemophilia: OMRF enters license agreement with Shanghai RAAS Blood Products
13 févr. 2018 15h02 HE
|
Oklahoma Medical Research Foundation
OKLAHOMA CITY, Feb. 13, 2018 (GLOBE NEWSWIRE) -- The Oklahoma Medical Research Foundation has entered a license agreement with Shanghai RAAS Blood Products Co., Ltd. Under the agreement, Shanghai...